Lexeo Therapeutics Inc.
Organization details
- Legal name
- Lexeo Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- LXEO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001907108
- EIN
- 85-4012572
Board of directors
-
Bernard Davitian · DirectorSince 2023
-
Brenda Cooperstone · DirectorSince 2023
-
Hauwermeiren Timothy Van · DirectorSince 2024
-
Laura Sepp-Lorenzino · DirectorSince 2026
-
Mette Kirstine Agger · DirectorSince 2023
-
Paula H. Cholmondeley · DirectorSince 2023
-
Reinaldo M. Diaz · DirectorSince 2023
-
Richard Nolan Townsend · Director · Chief Executive OfficerSince 2023
-
Steven Altschuler · DirectorSince 2023
-
Tolga Tanguler · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 25, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
74.4%
-
98.5%
-
98.6%
Board connections
4 of this board's directors also sit on 4 other boards. 3 are in the same sector.
-
Denali Therapeutics Inc. Same sectorvia Hauwermeiren Timothy Van
-
Senti Biosciences Holdings Inc. Same sectorvia Brenda Cooperstone
-
Taysha Gene Therapies Inc. Same sectorvia Laura Sepp-Lorenzino
- via Steven Altschuler
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $745,300
- 16 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Bhalla Narinder Pal Officer (Chief Medical Officer) | Grant or award | +2,714 | $3.58 | $9,716 |
| Sep 14, 2026 | Richard Nolan Townsend Director, Officer (Chief Executive Officer) | Grant or award | +2,306 | $2.64 | $6,088 |
| Sep 14, 2026 | Otero Jose Manuel Officer (Chief Operating Officer) | Grant or award | +2,110 | $2.64 | $5,570 |
| Aug 18, 2026 | Richard Nolan Townsend Director, Officer (Chief Executive Officer) | Open-market sale | −3,345 | $4.95 | $16,558 |
| Aug 18, 2026 | Otero Jose Manuel Officer (Chief Operating Officer) | Open-market sale | −1,304 | $4.96 | $6,468 |
| Aug 18, 2026 | Tamayo Louis Edward Officer (Chief Financial Officer) | Open-market sale | −4,117 | $4.91 | $20,214 |
| Jul 1, 2026 | Bhalla Narinder Pal Officer (Chief Medical Officer) | Open-market sale | −22,306 | $4.42 | $98,593 |
| Jul 1, 2026 | Richard Nolan Townsend Director, Officer (Chief Executive Officer) | Open-market sale | −25,947 | $4.48 | $116,243 |
| Jul 1, 2026 | Otero Jose Manuel Officer (Chief Operating Officer) | Open-market sale | −4,666 | $4.48 | $20,904 |
| Jul 1, 2026 | Tamayo Louis Edward Officer (Chief Financial Officer) | Open-market sale | −4,641 | $4.49 | $20,838 |
| Jun 29, 2026 | Bhalla Narinder Pal Officer (Chief Medical Officer) | Grant or award | +55,000 | — | — |
| Jun 29, 2026 | Richard Nolan Townsend Director, Officer (Chief Executive Officer) | Grant or award | +67,000 | — | — |
| Jun 29, 2026 | Otero Jose Manuel Officer (Chief Operating Officer) | Grant or award | +12,060 | — | — |
| Jun 29, 2026 | Tamayo Louis Edward Officer (Chief Financial Officer) | Grant or award | +12,000 | — | — |
| May 18, 2026 | Otero Jose Manuel Officer (Chief Operating Officer) | Open-market sale | −1,302 | $5.07 | $6,601 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Lexeo Therapeutics Inc.
Who is the CEO of Lexeo Therapeutics Inc.?
Richard Nolan Townsend has been Lexeo Therapeutics Inc.'s Chief Executive Officer since November 2023.
How many directors are on Lexeo Therapeutics Inc.'s board?
Lexeo Therapeutics Inc.'s board has 10 directors: Bernard Davitian, Brenda Cooperstone, Hauwermeiren Timothy Van, Laura Sepp-Lorenzino, Mette Kirstine Agger, Paula H. Cholmondeley, Reinaldo M. Diaz, Richard Nolan Townsend, Steven Altschuler and Tolga Tanguler.
Are Lexeo Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Lexeo Therapeutics Inc. insiders made no open-market purchases and sold $745,300 of shares in 16 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="lexeo-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.